Cytosine

Cytosine

SCHEMBL4065266

N.Nc1cc[nH]c(=O)n1

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cytosine SCHEMBL28686892 0.98 DYRK1A (0.41)
Cytosine SCHEMBL1330710 0.98
Cytosine SCHEMBL4059 0.98
Cytosine SCHEMBL4657334 0.98 DYRK1A (0.44)
Cytosine SCHEMBL1330400 0.98
Cytosine SCHEMBL19692377 0.95
Cytosine SCHEMBL10623341 0.95
Cytosine SCHEMBL2406920 0.95
Cytosine SCHEMBL21772310 0.95 DYRK1A (0.42)
Cytosine SCHEMBL4492966 0.95

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102206240-B Process for the synthesis of azacitidine and decitabine CHEMI SPA 2015-01-21 CN claimed
CN-102206240-A Process for the synthesis of azacitidine and decitabine CHEMI SPA 2011-10-05 CN claimed
CN-118974277-A Nucleic acid amplification with higher exponential radix than radix 2 using high and low Tm primers 赛沛公司 2024-11-15 CN disclosed
CN-117982528-A Application of schisandra chinensis polysaccharide in preparation of medicines for relieving DSS-induced ulcerative colitis of mice 江苏农牧科技职业学院 2024-05-07 CN disclosed
CN-105246918-B Growth hormone secretagogue receptor related protein, nucleic acid, preparation method and application thereof 王庆华 2019-11-05 CN disclosed
CN-109526222-A 5' -cyclic phosphonate modified nucleotide 箭头药业股份有限公司 2019-03-26 CN disclosed
CN-107260690-A Lyophilized formulations of Decitabine and preparation method thereof 江苏豪森药业集团有限公司 2017-10-20 CN disclosed
CN-106661579-A Methods and compositions for preventing ischemia-reperfusion injury in an organ 夸克制药公司 2017-05-10 CN disclosed
CN-101473045-B Methods and compositions for detecting autoimmune disorders 健泰科生物技术公司 2016-08-03 CN disclosed
CN-105327363-A Immunostimulatory oligonucleotides SELECTA BIOSCIENCES INC 2016-02-17 CN disclosed
CN-103347542-B Immunostimulatory oligonucleotides SELECTA BIOSCIENCES, INC. (US) 2015-09-16 CN disclosed
CN-1777363-A beta-L-2' -deoxynucleosides for the treatment of resistant HBV strains and combination therapy IDENIX CAYMAN LTD (KY) 2006-05-24 CN disclosed
CN-1745089-A immunostimulatory sequence oligonucleotides and methods of use DYNAVAX TECHNOLOGIES (US) 2006-03-08 CN disclosed
EP-1594882-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES Merck & Co., Inc. (US) 2005-11-16 EP disclosed
CN-1674878-A Immunomodulatory compositions, methods of making, and methods of use thereof DYNAVAX TECH CORP (US) 2005-09-28 CN disclosed
US-20050158770-A1 Microwave mediated synthesis of nucleic acid probes VENTANA MEDICAL SYSTEMS, INC. (US) 2005-07-21 US disclosed
WO-2005064018-A2 MICROWAVE MEDIATED SYNTHESIS OF NUCLEIC ACID PROBES VENTANA MEDICAL SYSTEMS, INC. (US) 2005-07-14 WO disclosed
WO-2004072090-A1 PROCESS FOR PREPARING BRANCHED RIBONUCLEOSIDES FROM 1, 2-ANHYDRORIBOFURANOSE INTERMEDIATES MERCK & CO. INC. (US) 2004-08-26 WO disclosed
CN-1392153-A Process for prparing cytidine compound MITSUBISHI CHEM IND (JP) 2003-01-22 CN disclosed
CN-1352696-A Adipose-derived stem cells and grids UNIV PITTSBURGH (US) 2002-06-05 CN disclosed